|
CLSPN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.32687260757348E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.7321035978598E-11 |
| Normal-vs-Stage2 |
1.63046999999139E-05 |
| Normal-vs-Stage3 |
1.05220000046202E-07 |
| Normal-vs-Stage4 |
1.89284999999595E-05 |
| Stage1-vs-Stage2 |
4.864200E-01 |
| Stage1-vs-Stage3 |
5.081800E-01 |
| Stage1-vs-Stage4 |
5.976400E-02 |
| Stage2-vs-Stage3 |
2.899000E-01 |
| Stage2-vs-Stage4 |
3.837800E-02 |
| Stage3-vs-Stage4 |
1.458570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.976263762695E-12 |
| Normal-vs-AfricanAmerican |
3.964600E-04 |
| Normal-vs-Asian |
1.023780E-01 |
| Caucasian-vs-AfricanAmerican |
9.538400E-03 |
| Caucasian-vs-Asian |
4.595600E-01 |
| AfricanAmerican-vs-Asian |
2.690000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.83649811708642E-11 |
| Normal-vs-Female |
2.4832003120423E-10 |
| Male-vs-Female |
7.093200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.418100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.48769996322073E-10 |
| Normal-vs-Age(61-80Yrs) |
7.95149945886919E-10 |
| Normal-vs-Age(81-100Yrs) |
1.576030E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.689000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.446400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.448400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.956600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.732230E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.346400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.061400E-03 |
| Normal-vs-Grade 2 |
1.75069958530116E-10 |
| Normal-vs-Grade 3 |
2.47609999171061E-09 |
| Normal-vs-Grade 4 |
1.72468999999342E-05 |
| Grade 1-vs-Grade 2 |
8.326000E-01 |
| Grade 1-vs-Grade 3 |
8.280000E-01 |
| Grade 1-vs-Grade 4 |
3.816100E-02 |
| Grade 2-vs-Grade 3 |
8.852400E-01 |
| Grade 2-vs-Grade 4 |
2.468100E-02 |
| Grade 3-vs-Grade 4 |
2.924000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.23194812526617E-12 |
| Normal-vs-ccB subtype |
4.95829999280772E-09 |
| ccA subtype-vs-ccB subtype |
3.080800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.59919990980495E-10 |
| Normal-vs-N1 |
1.143630E-02 |
| N0-vs-N1 |
1.546750E-01 |
|
|
